Fri, Apr 18, 2014, 7:19 AM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • shortningdough shortningdough Nov 6, 2007 11:54 PM Flag

    maybe it's good for adhd

    Shire says study did not meet primary endpoint

    By Angela Moore
    Last Update: 8:20 AM ET Nov 6, 2007Print Subscribe to RSS Disable Live Quotes

    NEW YORK (MarketWatch) - Shire Plc (SHPGY:SHPGY
    News, chart, profile, more
    Last:


    Delayed quote dataAdd to portfolio
    Analyst
    Create alertInsider
    Discuss
    Financials
    Sponsored by:
    SHPGY, , ) on Tuesday said a Phase II study of its drug Fosrenol drug did not meet its primary endpoint, to control serum phosphate within normal levels. The company said as a secondary endpoint, patients taking Fosrenol were found to have statistically significant reductions in serum phosphate levels after eight weeks of treatment compared with patients taking a placebo. Shares slipped 1% in premarket trading

 
SHPG
147.36+0.58(+0.40%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST